MIM
ZURA icon

MetLife Investment Management’s Zura Bio ZURA Stock Holding History

MetLife Investment Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,260
Closed -$111K – 2865
2024
Q3 		$111K Buy
+27,260
New +$102K ﹤0.01% 2584

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

MetLife Investment Management's ZURA Position: Q4 2024 in Review

MetLife Investment Management sold out of Zura Bio (ZURA) in Q4 2024, closing a stake of 27,260 shares — an estimated $111K sold.

MetLife Investment Management first reported a position in ZURA in Q3 2024 and held it in 1 quarter. The position peaked at $111K in Q3 2024. 87 funds tracked by Wall St. Rank hold ZURA as of Q4 2024.

  • MetLife Investment Management reported no remaining Zura Bio position as of Q4 2024 after selling out during the quarter.
  • MetLife Investment Management sold 27,260 Zura Bio shares in Q4 2024, an estimated $111K.
  • MetLife Investment Management first reported a position in Zura Bio in Q3 2024 and held it in 1 quarter.
  • MetLife Investment Management's Zura Bio position peaked at $111K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Zura Bio as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.